Endovascular renal artery denervation: Why, when, and how?

CardioVascular and Interventional Radiology

Volumn 35, Issue 3, 2012, Pages 463-471

  Sapoval, Marc ^a   Azizi, Michel ^a   Bobrie, Guillaume ^b   Cholley, Bernard ^a   Pagny, Jean Yves ^b   Plouin, Pierre François ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Arterial intervention; Hypertension; Kidney renal; Radiofrequency ablation

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; VASCULOTROPIN INHIBITOR;

ABDOMINAL AORTA ANEURYSM; ADRENAL DISEASE; AORTA ATHEROSCLEROSIS; ARTERY CATHETERIZATION; ARTERY SPASM; AUTONOMIC DENERVATION; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BRADYCARDIA; CATHETER ABLATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONSCIOUS SEDATION; DRUG ANTAGONISM; DRUG DOSE TITRATION; ENDOVASCULAR RENAL ARTERY DENERVATION; FOLLOW UP; HEART RATE; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY DENERVATION; KIDNEY DISEASE; NONHUMAN; PAIN; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RENAL ARTERY; RENOVASCULAR DISEASE; RESISTANT HYPERTENSION; REVIEW; SIDE EFFECT; URIC ACID BLOOD LEVEL; ANGIOGRAPHY; DENERVATION; DRUG RESISTANCE; INNERVATION; INTERVENTIONAL RADIOLOGY; METHODOLOGY; NEUROSURGERY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; SYMPATHECTOMY;

ANGIOGRAPHY; CATHETER ABLATION; DENERVATION; DRUG RESISTANCE; HUMANS; HYPERTENSION; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; RADIOGRAPHY, INTERVENTIONAL; RENAL ARTERY; SYMPATHECTOMY;

EID: 84864311083     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-011-0306-8     Document Type: Review

References (18)

1. Krum H, Schlaich MP, Whitbourn R et al (2009) Catheter based renal sympathetic denervation for reistant hypertension: a multicenter safety and proof-of-principle cohort study. Lancet 373: 1275-1281
2. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The symplicity HTN-2 trial): a randomised controlled trial. Lancet 376(9756):1903-1909
3. Uder M, Schmid A, Titze S, Schmieder R (2011) Renal artery denervation for the treatment of hypertension: opening up new horizons. Cardiovasc Intervent Radiol 34:442-444
4. Doumas M, Douma S (2010) Renal sympathetic denervation: the jury is still out. Lancet 376(9756):1878-1880
5. DiBona GFS (2002) Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 11:197-200
6. Schlaich MP, Sobotka PA, Krum H et al (2009) Renal denervation as a therapeutic approach for hypertension. Novel implication for an old concept. Hypertension 54:1195-1201
7. Mancia G, De Backer G, Dominiczak A et al (2007) Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens 25:1105-1187
8. O'Brien E, Asmar R, Beilin L et al (2005) European society of hypertension working group on blood pressure monitoring practice. Guidelines of the European society of hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 23:697-701
9. Calhoun DA, Jones D, Textor S et al (2008) American Heart Association Professional Education Committee resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 117:e510-e526
10. Mancia G, Laurent S, Agabiti-Rosei E et al (2009) Reappraisal of European guidelines on hypertension management: a European society of hypertension Task Force document. Blood Press 18:308-347
11. Stergiou GS, Myers MG, Reid JL et al (2010) Setting-up a blood pressure and vascular protection clinic: requirements of the European society of hypertension. J Hypertens 28:1780-1781
12. Streeten DHP, Anderson GH, Wagner S (1990) Effect of age on response to secondary hypertension to specific treatment. Am J Hypertens 3:360-365
13. Hirsch AT, Haskal ZJ, Hertzer NR et al (2006) ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation 113:e463-e654
14. Funder JW, Carey RM, Fardella C et al (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:3266-3281
15. Plouin PF, Gimenez-Roqueplo AP (2006) Pheochromocytomas and secreting paragangliomas. Orphanet J Rare Dis 1:49
16. Chernik DA, Gillings D, Laine H et al (1990) Validity and reliability of the observer's assessment of alertness/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol 10:244-251
17. Mancia G, De Backer G, Dominiczak A et al (2007) ESH-ESC task force on the management of arterial hypertension. ESH-ESC practice guidelines for the management of arterial hypertension. J Hypertens 25:1751-1762
18. Plouin PF, Bobrie G, Chatellier G (2001) How to manage hypertension in clinical practice, and what can be expected from a hypertension clinic. In: Zanchetti A (ed) Hypertension. McGraw-Hill Clinical Medicine Series, McGraw-Hill, New York, pp 241-251